Artificial Intelligence (AI) opens up a wide range of applications and is increasingly being used across all sectors of the industries. However, particular caution is advised, especially in regulated industries.
What requirements apply to the pharmaceutical and medical device industries? What needs to be considered when implementing a company-specific AI tool?
This topic is the focus of the specialized lecture by Manuel Goldstein, Senior Consultant gempex GmbH, at Lounges 2026:
AI in the GMP Environment – Regulations Overview, Case Study, Opportunities, and Risks
March 26, 2026, from 3:00 p.m. to 3:30 p.m.
The presentation provides an overview of the current regulatory background as outlined in the EU AI Act, EU MDR, and Annex 22. It critically examines whether AI can be used as an all-around expert in gaining know-how or knowledge management. How are the roles of customers and consultant changing?
Using a case study and insights into the implementation of AI at gempex, important milestones will be highlighted and lessons learned will be shared. Expert circles, AI policy, and tool development will be explained.
Interested parties can register for the event free of charge until March 23 using the code GBPRB on the organizer’s website.
For questions regarding “AI and GMP,” please contact Manuel Goldstein via contact@gempex.com.
This might also interest you:
GMP-Consultancy